CVKD

CVKD

USD

Cadrenal Therapeutics Inc. Common Stock

$15.000+0.090 (0.604%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$14.910

Hoch

$15.000

Tief

$14.625

Volumen

0.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

29.5M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.02M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $5.7Aktuell $15.000Hoch $22.901

Ähnliche Nachrichten

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $32 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cadrenal Therapeutics with a Buy and maintains $32 price target.

Mehr anzeigen
HC Wainwright & Co. Reiterates Buy on Cadrenal Therapeutics, Maintains $32 Price Target
BusinessWire

Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug

Mehr anzeigen
Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness